Beyond this rare disease, intriguing emerging evidence associates DEGS1 expression and aberrant levels of Cer and/or DhCer with the appearance of comorbidities in the context of obesity, including type 2 diabetes, insulin resistance, and cardiovascular diseases (12, 13, 14, 15, 16). Here, DEGS1 is linked to type 2 diabetes mellitus.